• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MedTech 100 roundup: Stocks show no signs of slowing down

MedTech 100 roundup: Stocks show no signs of slowing down

November 9, 2020 By Sean Whooley

MedTech 100 IndexThe medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now.

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the end of the week prior (Oct. 30).

This morning, after positive news broke regarding the effectiveness of Pfizer and BioNTech’s COVID-19 vaccine candidate, that total shot up even more, reaching the 100.65-point total at which it now sits. The recent news of Joe Biden’s election as president of the U.S. may have pushed medtech stocks in an upward direction, too.

Prior to today’s leap, last week’s peak saw the index sitting more than five points ahead of the pre-pandemic high of 92.32, which the market reached on Feb. 19, and now it appears the index is leaving any previous high points well behind it.

Medtech’s stock performance mirrored the overall markets, with the S&P 500 Index performing identically to the medtech index, growing by 7.3%. The Dow Jones Industrial Average fared similarly, increasing by 6.9%. Both those indexes have experienced massive jumps today upon the Pfizer/BioNTech news, too.

Medtech’s lowest point during the COVID-19 pandemic remains at 62.13 on March 23. Since then, the industry’s stocks have experienced 57.1% growth in total, as of the end of last week.

The industry continues to plug along and businesses continue to operate through the pandemic. Here are some of the major highlights from the past week as earnings season is in full swing:

  • The top 5 MassDevice stories of the week
  • Stryker to complete Wright Medical buy on Nov. 10
  • Oxford chief touts ‘small chance’ of having COVID-19 vaccine ready by Christmas
  • Teladoc closes $18.5B Livongo buy
  • Novocure closes $575M offering
  • BARDA gives Mesa Biotech $13M to develop COVID-19/flu test
  • TransMedics beats Street in Q3
  • COVID-19 diagnostics boost Hologic in Q4
  • Inspire Medical skyrockets on massive Q3 revenue beat

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: BioNTech, coronavirus, COVID-19, Hologic, Inspire Medical Systems Inc., Livongo, MedTech 100 Index, Mesa Biotech, NovoCure, Oxford University, Pfizer, Stryker, Teladoc, transmedics

More recent news

  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy